Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,608.50
Bid: 1,608.00
Ask: 1,608.50
Change: 8.50 (0.53%)
Spread: 0.50 (0.031%)
Open: 1,608.00
High: 1,616.00
Low: 1,604.50
Prev. Close: 1,600.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Fed comments provide support ahead of BoE, ECB

Thu, 07th Mar 2013 08:43

The FTSE 100 held on to recent gains on Thursday morning ahead of central-bank policy decisions in the UK and Europe, as comments from the Federal Reserve provided some support.According to the Fed's Beige Book released last night, the US economy expanded at a "modest to moderate pace" at the start of 2013 due to strong car sales, hiring gains and a recovery in the housing sector.The UK benchmark index surged to levels not seen since late 2007 earlier this week a better-than-expected reading of US services activity and a pledge by China to hit its growth targets this year boosted markets.It appears that markets were pausing for breath today ahead of policy decisions from the Bank of England and European Central Bank expected after midday. Speculation has increased over the last month about changes to policy from both sides so investors are likely to sit on their hands and refrain from taking risk until someone makes a move.Overnight, the Bank of Japan voted to keep interest rates and its asset purchase programme unchanged, a decision that was widely expected given the Bank's recent aggressive easing.FTSE 100: Aviva plummets after 'rebasing' diviInsurance giant Aviva was forced to slash to dividend after swinging into the red in 2012, after taking a 3.3bn-pound write-down on a disposal in the US. Aviva also said that its overall situation does not warrant bonuses for executive directors for 2012 or pay rises for 2013. Shares dropped sharply early on.Heading the other way was temporary power and temperature control provider Aggreko after posting a strong performance with trading profit up 13% last year.Insurance provider Standard Life gained after unveiling a windfall dividend worth £302m after delivering substantial growth in profits in 2012 underpinned by strong performance in the UK.British asset management firm Schroders was higher after saying that assets under management (AuM) reached record levels in spite of choppy markets and falling profits.Pharma giant GlaxoSmithKline rose after announcing positive data from a drug study through ViiV Healthcare, a global specialist HIV company set up by GSK in 2009.FTSE 250: National Express dropsTransport group National Express was a heavy faller after reports yesterday said that US investor Elliot Advisors plans to sell over 50m worth of shares, equal to a 9.9% stake.Engineering firm Spirax-Sarco was in demand after proposing a special dividend of 100p per share in addition to an 8.0% rise in the full-year payout, after a 2.0% rise in revenue in 2012.FTSE 100 - RisersAggreko (AGK) 1,932.00p +9.90%IMI (IMI) 1,328.00p +5.23%Admiral Group (ADM) 1,362.00p +2.10%Standard Life (SL.) 380.30p +1.63%Unilever (ULVR) 2,721.00p +1.45%Barclays (BARC) 306.50p +1.44%Reckitt Benckiser Group (RB.) 4,568.00p +1.15%Antofagasta (ANTO) 1,075.00p +1.03%Kazakhmys (KAZ) 560.50p +0.99%Schroders (SDR) 2,056.00p +0.98%FTSE 100 - FallersAviva (AV.) 310.80p -13.62%Melrose Industries (MRO) 260.10p -2.62%Polymetal International (POLY) 958.00p -1.79%British Sky Broadcasting Group (BSY) 874.00p -1.63%Morrison (Wm) Supermarkets (MRW) 259.20p -1.52%Lloyds Banking Group (LLOY) 50.30p -1.41%Serco Group (SRP) 621.50p -0.88%Vodafone Group (VOD) 178.60p -0.78%Legal & General Group (LGEN) 164.90p -0.66%Old Mutual (OML) 208.80p -0.62%FTSE 250 - RisersRegus (RGU) 149.50p +4.18%Spirax-Sarco Engineering (SPX) 2,578.00p +3.00%RIT Capital Partners (RCP) 1,202.00p +2.56%SEGRO (SGRO) 264.60p +2.44%Cobham (COB) 234.20p +2.18%Betfair Group (BET) 702.00p +2.03%Jupiter Fund Management (JUP) 344.60p +1.83%Ashtead Group (AHT) 585.00p +1.74%Rotork (ROR) 2,951.00p +1.58%SIG (SHI) 142.50p +1.50%FTSE 250 - FallersNational Express Group (NEX) 206.90p -10.04%Petropavlovsk (POG) 257.10p -6.34%Hunting (HTG) 889.50p -4.51%Inmarsat (ISAT) 636.50p -4.36%IP Group (IPO) 135.00p -3.23%Balfour Beatty (BBY) 279.30p -2.68%Heritage Oil (HOIL) 192.50p -2.19%International Personal Finance (IPF) 463.90p -2.01%African Barrick Gold (ABG) 241.10p -1.87%Rank Group (RNK) 163.00p -1.69%BC
More News
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more
26 Oct 2023 09:19

TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China

(Alliance News) - GSK PLC on Thursday said its subsidiary ViiV Healthcare has received marketing authorisation in China for its cabotegravir treatment, marketed as Vocabria.

Read more
26 Oct 2023 07:02

GSK HIV injection regimen gets approval in China

(Sharecast News) - GSK announced on Thursday that its majority-owned HIV specialist subsidiary ViiV has received approval from the National Medical Products Administration (NMPA) of China for an injection regimen.

Read more
25 Oct 2023 16:01

UK earnings, trading statements calendar - next 7 days

Thursday 26 October 
Bank of Ireland Group PLCTrading Statement
Bloomsbury Publishing PLCHalf Year Results
Botswana Diamonds PLCTrading Statement
C&C Group PLCHalf Year Results
e-Therapeutics PLCHalf Year Results
Financials Acquisition CorpTrading Statement
GCP Infrastructure Investments LtdTrading Statement
HarbourVest Global Private Equity LtdHalf Year Results
Hummingbird Resources PLCTrading Statement
Hunting PLCTrading Statement
Inchcape PLCTrading Statement
International Personal Finance PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Renishaw PLCTrading Statement
Standard Chartered PLCQ3 Results
Unilever PLCTrading Statement
WPP PLCTrading Statement
Friday 27 October 
International Consolidated Airlines Group SAQ3 Results
NatWest Group PLCQ3 Results
Monday 30 October 
Airtel Africa PLCHalf Year Results
Computacenter PLCTrading Statement
Glencore PLCTrading Statement
HSBC Holdings PLCQ3 Results
Lok'n Store Group PLCFull Year Results
Pearson PLCTrading Statement
Tuesday 31 October 
BP PLCQ3 Results
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCFull Year Results
Georgia Capital PLCQ3 Results
Grit Real Estate Income Group LtdFull Year Results
RHI Magnesita NVTrading Statement
Spectris PLCQ3 Results
TP ICAP Group PLCTrading Statement
UP Global Sourcing Holdings PLCFull Year Results
Wednesday 1 November 
Asos PLCFull Year Results
Aston Martin Lagonda Global Holdings PLCQ3 Results
Beximco Pharmaceuticals LtdFull Year Results
GSK PLCQ3 Results
Next PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Weir Group PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
25 Oct 2023 09:35

GSK says RSV jab shows promising response in adults aged 50 to 59

(Alliance News) - GSK PLC on Wednesday said a trial found its respiratory syncytial virus vaccine Arexy delivered an immune response in adults aged 50 to 59.

Read more
25 Oct 2023 07:27

GSK hails success in US RSV vaccine trial

(Sharecast News) - Pharma giant GSK has announced positive preliminary results from a trial of its Arexvy vaccine to treatment respiratory syncytial virus (RSV) disease for a younger patient population in the US.

Read more
16 Oct 2023 08:09

TOP NEWS: GSK receives positive EU opinion on Jemperli for cancer

(Alliance News) - GSK PLC on Monday said its monoclonal antibody Jemperli is closer to becoming the first new frontline treatment option in the EU in decades for a certain form of endometrial cancer.

Read more
16 Oct 2023 07:44

LONDON BRIEFING: Hipgnosis pulls interim dividend on lower royalties

(Alliance News) - The FTSE 100 is likely to open higher on Monday, benefitting from higher oil and gas prices, while fears of escalating regional conflict in the Middle East damp risk sentiment elsewhere.

Read more
16 Oct 2023 07:16

GSK nears green light for Jemperli usage in Europe

(Sharecast News) - Pharma giant GSK has announced that European experts recommended the approval of its Jerperli drug for the treatment of a specific type of endometrial cancer - paving the way for marketing authorisation by the continent's regulatory body.

Read more
11 Oct 2023 11:51

GSK settles California Zantac lawsuit

(Sharecast News) - GSK has agreed to settle another lawsuit concerning its discontinued heartburn treatment Zantac, the drugs giant confirmed on Wednesday.

Read more
11 Oct 2023 09:17

LONDON BROKER RATINGS: JPMorgan raises Croda; Berenberg cuts Atalaya

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
11 Oct 2023 08:51

LONDON MARKET OPEN: FTSE 100 higher; Travis Perkins warns on profit

(Alliance News) - Stock prices in London opened largely higher on Wednesday as market mood remained resilient, despite the continuing conflict in the Middle East, amid a softening of rhetoric from the US central bank.

Read more
11 Oct 2023 08:36

TOP NEWS: GSK reaches settlement for Zantac litigation in California

(Alliance News) - GSK PLC on Wednesday said that it has reached a confidential settlement in the Cantlay/Harper case, which alleged that the firm's heartburn medication can cause cancer.

Read more
11 Oct 2023 07:47

LONDON BRIEFING: Stocks lower; GSK settles Zantac case in California

(Alliance News) - Stocks in London are set to open lower on Wednesday as investor looked ahead to the release of the US Federal Reserve's September meeting minutes later in the day.

Read more
9 Oct 2023 08:16

TOP NEWS: GSK inks agreement with Zhifei to promote shingles vaccine

(Alliance News) - GSK PLC on Monday said it has reached an exclusive agreement with Chongqing Zhifei Biological Products Ltd to co-promote its shingles vaccine, Shingrix, in China.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.